Advertisement

Topics

Stemline Presents SL-401 Updated Stage 1 And 2 Data From Ongoing Pivotal Trial In BPDCN And Safety Experience Across Multiple Indications, Today At European Hematology Association

20:00 EDT 22 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Stemline Presents SL-401 Updated Stage 1 And 2 Data From Ongoing Pivotal Trial In BPDCN And Safety Experience Across Multiple Indications, Today At European Hematology Association

NEXT ARTICLE

More From BioPortfolio on "Stemline Presents SL-401 Updated Stage 1 And 2 Data From Ongoing Pivotal Trial In BPDCN And Safety Experience Across Multiple Indications, Today At European Hematology Association"

Advertisement
Quick Search
Advertisement
Advertisement